Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
Authors Bajwa A, Khurana G, Kimpel D, Reddy A
Received 26 February 2015
Accepted for publication 26 March 2015
Published 28 May 2015 Volume 2015:8 Pages 121—126
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Scott Fraser
Asima Bajwa,1 Gitanjali Khurana,2 Donald Kimpel,2 Ashvini K Reddy1
1Department of Ophthalmology, University of Virginia, Charlottesville, VA, USA; 2Division of Clinical Rheumatology, Department of Internal Medicine, University of Virginia, Charlottesville, VA, USA
Objective: The proportion of patients with systemic lupus erythematosus (SLE) who manifest retinal involvement increases many fold in patients with active systemic disease. The objective of this report is to stress upon the significance of comprehensive ophthalmic assessment of all SLE patients to prevent and manage blinding ocular manifestations of the disease.
Methods: Retrospective case review.
Results: Incidental retinal vascular complications seen in patients undergoing baseline hydroxychloroquine screening.
Conclusion: The purpose of comprehensive ophthalmic screening in SLE patients is twofold. It will aid in the diagnosis and treatment of blinding ocular complications of the disease and monitor hydroxychloroquine macular toxicity.
Keywords: systemic lupus erythematosus, hydroxychloroquine, retinal vein occlusion, retinal artery occlusion
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]